Evidence map›Paper›PMID 42879317›Full record

ArticleBriefings in bioinformatics2026

Assessing the impact of parental linear gene normalization on the performance of statistical models for circular RNA differential expression analysis.

Erda Qorri, Valentin Varga, Katalin Priskin, Dóra Latinovics, Bertalan Takács, Emese Pekker, Gábor Jaksa, Bernadett Csányi, László Torday, Ali Bassam and 3 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Erda QorriHUN-REN BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Temesvári krt. 62, 6726, Hungary.
Valentin VargaHUN-REN BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Temesvári krt. 62, 6726, Hungary.
Katalin PriskinDelta Bio 2000 Ltd., Szeged, Temesvári krt. 58-60, 6726, Hungary.
Dóra LatinovicsDelta Bio 2000 Ltd., Szeged, Temesvári krt. 58-60, 6726, Hungary.
Bertalan TakácsHUN-REN BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Temesvári krt. 62, 6726, Hungary.
Emese PekkerHUN-REN BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Temesvári krt. 62, 6726, Hungary.
Gábor JaksaDelta Bio 2000 Ltd., Szeged, Temesvári krt. 58-60, 6726, Hungary.
Bernadett CsányiDelta Bio 2000 Ltd., Szeged, Temesvári krt. 58-60, 6726, Hungary.
László TordayCenter of Clinical Oncology and Radiotherapy, Békés County Central Hospital, Gyula, Semmelweis u. 1, 5700, Hungary.
Ali BassamCenter of Clinical Oncology and Radiotherapy, Békés County Central Hospital, Gyula, Semmelweis u. 1, 5700, Hungary.
Zsuzsanna KahánDepartment of Oncotherapy, University of Szeged, Szeged, Korányi fasor 12, 6720, Hungary.
Lajos PintérEuropean Life Technologies Hungary PLC, Szeged, Temesvári krt. 58-60, 6726, Hungary.
Lajos HaracskaHUN-REN BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Temesvári krt. 62, 6726, Hungary.ORCID 0000-0003-3608-5897

Funding

National Research, Development, and Innovation Office 2023-1.1.1-PIACI_FÓKUSZ-2024-00029National Research, Development, and Innovation Office 2024-1.1.1-KKV_FÓKUSZ-2024-00019National Research, Development, and Innovation Office TKP-31-8/PALY-2021, 2025-1.1.2-GYORSÍTÓSÁV-2025-00038
6 · The paper itself

Abstract

backgroundCircular RNAs (circRNAs) have emerged as promising non-invasive cancer biomarkers due to their stability, abundance in body fluids, and regulatory potential. However, circRNA differential expression analysis (DEA) remains challenging, owing to a lack of consensus on important preprocessing strategies such as filtering and normalization. While well-established bulk RNA-sequencing frameworks are commonly applied to circRNA data, newer approaches such as CIRI-DE (part of CIRI3 suite) integrate linear and circular transcript information to improve detection. Despite developments, an assessment of these integrative strategies is lacking, and the critical impact of filtering on DEA model performance has not been comprehensively evaluated.

resultsIn this study, we evaluated the impact of multiple normalization and filtering strategies on circRNA DEA using experimental datasets, including two in-house blood platelet sets and semi-parametric simulated in silico datasets. Our results emphasize the importance of selecting an appropriate filtering threshold, as overly lenient filtering can reduce model performance across datasets. We found edgeR's filterByExpr() strategy particularly effective in handling zero counts in circRNA data, while also generating the most reliable results across most datasets.Furthermore, by incorporating linear and circular information as described in CIRI-DE, most methods identified a higher number of DE circRNAs compared to circular counts alone. Notably, circRNAs identified by both CIRI-DE and the modified bulk RNA-sequencing pipelines showed substantial overlap.

conclusionOur findings demonstrate that automated filtering combined with linear-aware normalization significantly enhances the sensitivity and reproducibility of circRNA DEA, providing a standardized framework for more reliable biomarker discovery in transcriptomic research.

Indexed as

Gene Expression ProfilingModels, StatisticalRNA, CircularHumansSequence Analysis, RNARNA, CircularbenchmarkingbiomarkerscircRNADEAliquid biopsyplatelets

Identifiers

PMID42879317
PMCPMC13671228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.